Elekta AB (publ) (OTCMKTS:EKTAY) Rating Increased to Hold at Sanford C. Bernstein

Sanford C. Bernstein upgraded shares of Elekta AB (publ) (OTCMKTS:EKTAY - Free Report) from a strong sell rating to a hold rating in a report published on Wednesday morning,Zacks.com reports.

Elekta AB (publ) Stock Down 1.7 %

OTCMKTS:EKTAY traded down $0.10 on Wednesday, reaching $5.77. 2,918 shares of the stock traded hands, compared to its average volume of 10,592. The company has a current ratio of 1.05, a quick ratio of 0.81 and a debt-to-equity ratio of 0.60. The company has a market capitalization of $2.21 billion, a price-to-earnings ratio of 23.08 and a beta of 1.22. Elekta AB has a 12 month low of $5.25 and a 12 month high of $8.24. The company's fifty day simple moving average is $5.63 and its 200 day simple moving average is $6.10.

Elekta AB (publ) (OTCMKTS:EKTAY - Get Free Report) last issued its earnings results on Wednesday, November 27th. The company reported $0.06 EPS for the quarter. Elekta AB (publ) had a return on equity of 11.07% and a net margin of 5.65%. Equities analysts predict that Elekta AB will post 0.36 EPS for the current fiscal year.

About Elekta AB (publ)

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services.